TickerFacts.

Creative Medical Technology Holdings, Inc. (CELZ): Gross Profit

Annual figures by period end, from SEC filings.

$3.8K
Year ended 2025-12-31
$2.0K
Trailing 12 months to 2026-06-30
-60.1%
3-year compound annual growth
-49.3%
5-year compound annual growth
$120.0K2016-12-31: $02017-12-31: -$3.2K2018-12-31: $54.0K2019-12-31: $120.0K2020-12-31: $113.9K2021-12-31: $39.8K2022-12-31: $60.1K2023-12-31: $5.4K2024-12-31: $6.6K2025-12-31: $3.8K$3.8K
2016-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$3.8K-42.3%2026-03-20, From 2025-01-01
2024-12-31$6.6K+22.2%2026-03-20, From 2024-01-01
2023-12-31$5.4K-91.0%2025-03-14, From 2023-01-01
2022-12-31$60.1K+51.0%2024-03-22, From 2022-01-01
2021-12-31$39.8K-65.1%2023-03-31, From 2021-01-01
2020-12-31$113.9K-5.1%2022-03-30, From 2020-01-01
2019-12-31$120.0K+122.1%2021-03-17, From 2019-01-01
2018-12-31$54.0Kn/m2020-04-06, From 2018-01-01
2017-12-31-$3.2Kn/a2019-04-01, From 2017-01-01
2016-12-31$0n/a2018-03-29, From 2016-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Creative Medical Technology Holdings, Inc. (CELZ)2025-12-31$3.8K-42.3%
Entera Bio Ltd. (ENTX)2025-12-31$0-100.0%
Zivo Bioscience, Inc. (ZIVO)2024-12-31$49.0K+321.6%
Pluri Inc. (PLUR)2026-06-30$453.0K-30.7%
Scinai Immunotherapeutics Ltd. (SCNI)2025-12-31-$2.65Mn/m
Outlook Therapeutics, Inc. (OTLK)2025-09-30$57.2Kn/a
Humacyte, Inc. (HUMA)2025-12-31-$7.66Mn/a
Dyadic International Inc (DYAI)2025-12-31$770.5K-66.5%
Zeo ScientifiX, Inc. (ZEOX)2025-10-31$4.27M+13.0%

Compare CELZ, ENTX, ZIVO, PLUR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗